Gene expression profiling of non-small-cell lung cancer

References

• Parkin M, Samet J, Tyczynski et al. Chapter 1. Lung cancer epidemiology and etiology. In: Pathology & Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (Eds). IARC Press, Lyon, France 12–15 (2004).
   Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J. Clin.55(2), 74–108 (2005).
   PubMed Web of Science ®Google Scholar
• Furak J, Trojan I, Szoke T et al. Bronchioloalveolar lung cancer: occurrence, surgical treatment and survival. Eur. J. Cardiothorac. Surg.23(5), 818–823 (2003).
   Google Scholar
• Bertucci F, Houlgatte R, Nguyen C et al. Gene expression profiling of cancer by use of DNA arrays: how far from the clinic? Lancet Oncol.2(11), 674–682 (2001).
   Google Scholar
• Macgregor PF. Gene expression in cancer: the application of microarrays. Expert Rev. Mol. Diagn.3(2), 185–200 (2003).
   PubMed Web of Science ®Google Scholar
• Quackenbush J. Microarray analysis and tumor classification. N. Engl. J. Med.354(23), 2463–2472 (2006).
   PubMed Web of Science ®Google Scholar
• Raetz EA, Moos PJ. Impact of microarray technology in clinical oncology. Cancer Invest.22(2), 312–320 (2004).
   PubMed Web of Science ®Google Scholar
• Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev.3(10), 733–744 (2003).
   Google Scholar
• Hecht SS. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol.3(8), 461–469 (2002).
   PubMed Web of Science ®Google Scholar
• Stellman SD, Muscat JE, Thompson S, Hoffmann D, Wynder EL. Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking. Cancer80(3), 382–388 (1997).
   PubMedGoogle Scholar
• Mao L. Recent advances in the molecular diagnosis of lung cancer. Oncogene21(45), 6960–6969 (2002).
   PubMed Web of Science ®Google Scholar
• Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu. Rev. Physiol.64, 681–708 (2002).
   PubMed Web of Science ®Google Scholar
• Brambilla E, Gazzeri S, Moro D et al. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions. Clin. Cancer Res.5(2), 243–250 (1999).
   PubMed Web of Science ®Google Scholar
• Sozzi G, Pastorino U, Moiraghi L et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res.58(22), 5032–5037 (1998).
   PubMedGoogle Scholar
• Virmani AK, Fong KM, Kodagoda D et al. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer21(4), 308–319 (1998).
   PubMed Web of Science ®Google Scholar
• Westra WH, Baas IO, Hruban RH et al. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res.56(9), 2224–2228 (1996).
   PubMed Web of Science ®Google Scholar
• Wistuba, II, Mao L, Gazdar AF. Smoking molecular damage in bronchial epithelium. Oncogene21(48), 7298–7306 (2002).
   Google Scholar
• Wistuba II, Gazdar AF. Lung cancer preneoplasia. Annu. Rev. Path. Mech. Dis.1, 331–348 (2006).
   PubMed Web of Science ®Google Scholar
• Yashima K, Litzky LA, Kaiser L et al. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res.57(12), 2373–2377 (1997).
   PubMed Web of Science ®Google Scholar
• Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest122(3), 1037–1057 (2002).
   PubMed Web of Science ®Google Scholar
• Naruke T, Goya T, Tsuchiya R,Suemasu K. Prognosis and survival in resected lung carcinoma based on thenew international staging system. J. Thorac. Cardiovasc. Surg.96(3), 440–447 (1988).
   PubMed Web of Science ®Google Scholar
• Pairolero PC, Williams DE, Bergstralh EJ et al. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann. Thorac. Surg.38(4), 331–338 (1984).
   PubMed Web of Science ®Google Scholar
• Williams DE, Pairolero PC, Davis CS et al. Survival of patients surgically treated for stage I lung cancer. J. Thorac.Cardiovasc. Surg.82(1), 70–76 (1981).
   PubMed Web of Science ®Google Scholar
• Horio Y, Takahashi T, Kuroishi T et al. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res.53(1), 1–4 (1993).
   PubMed Web of Science ®Google Scholar
• Slebos RJ, Kibbelaar RE, Dalesio O et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med.323(9), 561–565 (1990).
   PubMed Web of Science ®Google Scholar
• Bustin SA, Nolan T. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J. Biomol. Tech.15(3), 155–166 (2004).
   PubMedGoogle Scholar
• Blackhall FH, Pintilie M, Wigle DA et al. Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection. Neoplasia6(6), 761–767 (2004).
   Google Scholar
• Brazma A, Hingamp P, Quackenbush J et al. Minimum information about a microarray experiment (MIAME) – toward standards for microarray data. Nat. Genet.29(4), 365–371 (2001).
   PubMed Web of Science ®Google Scholar
• Dobbin KK, Beer DG, Meyerson M et al. Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin. Cancer Res.11(2 Pt 1), 565–572 (2005).
   PubMed Web of Science ®Google Scholar
• Shi L, Reid LH, Jones WD et al.The microarray quality control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol.24(9), 1151–1161 (2006).
   PubMed Web of Science ®Google Scholar
• Allison DB, Cui X, Page GP, Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat. Rev. Genet.7(1), 55–65 (2006).
   PubMed Web of Science ®Google Scholar
• Auer H, Lyianarachchi S, Newsom D et al. Chipping away at the chip bias: RNA degradation in microarray analysis. Nat. Genet.35(4), 292–293 (2003).
   PubMed Web of Science ®Google Scholar
• Michiels S, Koscielny S, Hill C. Interpretation of microarray data in cancer. Br. J. Cancer96(8), 1155–1158 (2007).
   PubMed Web of Science ®Google Scholar
• Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA95(25), 14863–14868 (1998).
   PubMed Web of Science ®Google Scholar
• Tavazoie S, Hughes JD, Campbell MJ, Cho RJ, Church GM. Systematic determination of genetic network architecture. Nat. Genet.2s2(3), 281–285 (1999).
   Google Scholar
• Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet365(9458), 488–492 (2005).
   PubMed Web of Science ®Google Scholar
• Beer DG, Kardia SL, Huang CC et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med.8(8), 816–824 (2002).
   PubMed Web of Science ®Google Scholar
• Bhattacharjee A, Richards WG, Staunton J et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl Acad. Sci. USA98(24), 13790–13795 (2001).
   PubMed Web of Science ®Google Scholar
• Garber ME, Troyanskaya OG, Schluens Ket al. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl Acad. Sci. USA98(24), 13784–13789 (2001).
   PubMed Web of Science ®Google Scholar
• Hayes DN, Monti S, Parmigiani G et al. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. J. Clin. Oncol.24(31), 5079–5090 (2006).
   PubMed Web of Science ®Google Scholar
• Jiang H, Deng Y, Chen HS et al. Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes. BMC Bioinformatics5, 81 (2004).
   PubMed Web of Science ®Google Scholar
• Lu Y, Lemon W, Liu PY et al. A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. PLoS Med.3(12), E467 (2006).
   PubMed Web of Science ®Google Scholar
• Parmigiani G, Garrett-Mayer ES, Anbazhagan R, Gabrielson E. A cross-study comparison of gene expression studies for the molecular classification of lung cancer. Clin. Cancer Res.10(9), 2922–2927 (2004).
   PubMed Web of Science ®Google Scholar
• Barrett T, Troup DB, Wilhite SE et al. NCBI GEO: mining tens of millions of expression profiles – database and tools update. Nucleic Acids Res.35(Database issue), D760–D765 (2007).
   PubMed Web of Science ®Google Scholar
• Edgar R, Domrachev M, Lash AE.Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res.30(1), 207–210 (2002).
   PubMed Web of Science ®Google Scholar
• Rhodes DR, Yu J, Shanker K et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia6(1), 1–6 (2004).
   PubMed Web of Science ®Google Scholar
• Wigle DA, Tsao M, Jurisica I. Making sense of lung-cancer gene-expression profiles. Genome Biol.5(2), 309 (2004).
   Google Scholar
• Raponi M, Zhang Y, Yu J et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res.66(15), 7466–7472 (2006).
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Tomida S, Yatabe Y et al. Expression profile-defined classificationof lung adenocarcinoma shows close relationship with underlying majorgenetic changes and clinicopathologic behaviors. J. Clin. Oncol.24(11), 1679–1688 (2006).
   PubMed Web of Science ®Google Scholar
• Hofmann HS, Bartling B, Simm A et al. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array. Oncol. Rep.16(3), 587–595 (2006).
   PubMed Web of Science ®Google Scholar
• Virtanen C, Ishikawa Y, Honjoh D et al. Integrated classification of lung tumors and cell lines by expression profiling. Proc. Natl Acad. Sci. USA99(19), 12357–12362 (2002).
   PubMed Web of Science ®Google Scholar
• Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat. Genet.33(1), 49–54 (2003).
   PubMed Web of Science ®Google Scholar
• Wigle DA, Jurisica I, Radulovich N et al. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Res.62(11), 3005–3008 (2002).
   PubMed Web of Science ®Google Scholar
• Bild AH, Yao G, Chang JT et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature439(7074), 353–357 (2006).
   PubMed Web of Science ®Google Scholar
• Chen HY, Yu SL, Chen CH et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N. Engl. J. Med.356(1), 11–20 (2007).
   PubMed Web of Science ®Google Scholar
• Potti A, Mukherjee S, Petersen R et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N. Engl. J. Med.355(6), 570–580 (2006).
   PubMed Web of Science ®Google Scholar
• Bianchi F, Nuciforo P, Vecchi M et al. Survival prediction of stage I lung adenocarcinomas by expression of 10 genes. J. Clin. Invest.117(11), 3436–3444 (2007).
   PubMed Web of Science ®Google Scholar
• Rosell R, Danenberg KD, Alberola V et al. Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. Clin. Cancer Res.10(4), 1318–1325 (2004).
   PubMed Web of Science ®Google Scholar
• Larsen JE, Pavey SJ, Passmore LH et al. Expression profiling defines a recurrence signature in lung squamous cell carcinoma. Carcinogenesis28(3), 760–766 (2007).
   PubMed Web of Science ®Google Scholar
• Larsen JE, Pavey SJ, Passmore LH et al. Gene expression signature predicts recurrence in lung adenocarcinoma. Clin. Cancer Res.13(10), 2946–2954 (2007).
   Google Scholar
• Sun Z, Yang P, Aubry MC et al. Can gene expression profiling predict survival for patients with squamous cell carcinoma of the lung? Mol. Cancer3(1), 35 (2004).
   Google Scholar
• Inamura K, Shimoji T, Ninomiya H et al. A metastatic signature in entire lung adenocarcinomas irrespective of morphological heterogeneity. Hum. Pathol.38(5), 702–709 (2007).
   PubMed Web of Science ®Google Scholar
• Talbot SG, Estilo C, Maghami E et al. Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung. Cancer Res.65(8), 3063–3071 (2005).
   PubMed Web of Science ®Google Scholar
• Blackhall FH, Wigle DA, Jurisica I et al. Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study. Lung Cancer46(2), 197–204 (2004).
   PubMed Web of Science ®Google Scholar
• Sun Z, Yang P. Gene expression profiling on lung cancer outcome prediction: present clinical value and future premise. Cancer Epidemiol. Biomarkers Prev.15(11), 2063–2068 (2006).
   PubMed Web of Science ®Google Scholar
• Powell CA, Spira A, Derti A et al.Gene expression in lung adenocarcinomas of smokers and nonsmokers. Am. J. Resp. Cell Mol. Biol.29(2), 157–162 (2003).
   PubMed Web of Science ®Google Scholar
• Spira A, Beane JE, Shah V et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat. Med.13(3), 361–366 (2007).
   PubMed Web of Science ®Google Scholar
• Wachi S, Yoneda K, Wu R. Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics21(23), 4205–4208 (2005).
   PubMed Web of Science ®Google Scholar
• Yamagata N, Shyr Y, Yanagisawa K et al. A training-testing approach to the molecular classification of resected non-small cell lung cancer. Clin. Cancer Res.9(13), 4695–4704 (2003).
   PubMedGoogle Scholar
• Stearman RS, Dwyer-Nield L, Zerbe L et al. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am. J. Pathol.167(6), 1763–1775 (2005).
   PubMed Web of Science ®Google Scholar